The Connecticut Department of Public Health (DPH) is applying for ELC funding to support critical core capacity for DPH programs and the DPH State Public Health Laboratory (SPHL) so DPH can meet new infectious disease public health challenges. The Mission and Vision of DPH includes protecting and improving the health and safety of the people of Connecticut to ensure “healthy people in healthy Connecticut communities”. In March 2014, DPH published Healthy Connecticut 2020, a state health assessment and health improvement plan that is Connecticut’s translation of the national Healthy People 2020 initiatives to provide a framework for health promotion, disease prevention, and reducing health disparities. In March 2017, DPH was awarded national accreditation by the Public Health Accreditation Board (PHAB) having met the comprehensive PHAB assessment, including and evaluation of DPH’s ability to carry out the 10 Essential Public Health Services. As part of these efforts, DPH has developed a Healthy Connecticut 2020 Performance Dashboard to display key Connecticut population health indicators, including those for infectious disease prevention and control that is accessible to the public. In January 2019, DPH published its updated Strategic Plan 2019–2023, including a Strategic Map outlining the areas of continued focus for DPH. ELC funding is crucial for DPH to address the ELC core areas and strategies and achieve the short-, mid-, and long-term outputs in the ELC Roadmap.
The DPH Infectious Disease Section programs rely on ELC and other cooperative agreement funding to sustain and enhance ELC activities. These activities are critical to achieve long-term outcomes of reducing infectious disease morbidity and mortality, improving laboratory and surveillance system integration, and increasing timeliness of disease reporting for case management and follow up. During the next 5-year ELC funding cycle DPH Infectious Disease and the DPH State Public Health Laboratory (SPHL) will focus on priority pathogens and continue or expand activities, including the following: Cross Cutting A EPI and Lab, Cross Cutting Program Administration, Cross Cutting Health Information Systems, Program F – Foodborne, Waterborne, Enteric, and Environmentally Transmitted Diseases, Program G – Healthcare-associated Infections and Antibiotic Resistance Program, Program H – Vector-borne Diseases, Project I – Mycotics, Project M – Rabies Surveillance, Project O – Enhanced Vaccine-Preventable Disease, Project P -- Legionnaires’ Disease Prevention, Project Q -- Influenza Surveillance and Diagnostic Testing, and Project R – Non-influenza Respiratory Diseases.